Applications being accepted to Canadian Life Sciences CTA in San Francisco
The Consulate General of Canada in San Francisco is currently accepting applications from Canadian life sciences companies for our CTA@SFLifeSciences program located at QB3. Applications for our fall cohort (October 1st, 2014 – March 31st, 2015) will be accepted until August 29th, 2014.
The CTA@SFLifeSciences program provides Canadian companies an opportunity to grow in a commercialization hub. The Bay Area is an integral part of the global value chain and a world-renowned centre for life sciences. This region is also home to some of the largest and most active life sciences-oriented venture capital firms. Furthermore, the Bay Area accounts for one third of all venture capital investment in the United States. In addition to the risk capital ecosystem, traditional industry players like Genentech, Kaiser Permanente, McKesson, and Gilead are headquartered in the region. While biopharma is a strength of the Bay Area, Health IT is a dominant subsector that continues to present tangible opportunities for innovative Canadian companies. Essentially, the Bay Area presents growth opportunities for Canadian companies spanning a wide range of subsectors.
Our program seeks to facilitate the ongoing success of Canadian life sciences companies by embracing growth opportunities and providing access to the unique resources of this region. The CTA program offers office space within the prestigious Quantitative Biosciences Institute (QB3) where companies will be immersed in an ecosystem that fosters entrepreneurship, mentorship, and collaboration. During the six month cohort, participants will be provided an expert mentor along with access to advisors, service providers, successful expatriates within the industry, and various events within the local life sciences community.
Interested companies should apply online. Five spots are available and companies will be selected based on differentiated technology, in-Canada validation, and growth potential.
For more information, visit http://www.tradecommissioner.gc.ca/eng/document.jsp?did=153329